The importance of bismuth-containing quadruple therapy in Helicobacter pylori eradication in an era of increasing antibiotic resistance
Approximately half of the global population is infected with Helicobacter pylori (Hp). Currently, the main challenge in the field of Hp is that the antibiotic resistance of Hp is increased, leading to the decreased efficacy of regimens. The prevalence of Hp primary resistance to clarithromycin, metr...
Saved in:
Main Authors: | Yi HU, Yuan ZHUANG, Nong-Hua LYU |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of New Medicine
2020-06-01
|
Series: | Yixue xinzhi zazhi |
Subjects: | |
Online Access: | https://yxxz.whuznhmedj.com/storage/attach/2007/ET0pGUFwdhs3VNMC3FV52OnFYuTwn71ZtBC00ZMn.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bismuth-Based Quadruple Therapy as First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Prospective Randomized Comparison of 7- and 14-Day Treatment Regimens
by: Chul-Hyun Lim, et al.
Published: (2024-11-01) -
In Vitro Susceptibility and Synergistic Effect of Bismuth Against <i>Helicobacter pylori</i>
by: Jieun Woo, et al.
Published: (2024-10-01) -
Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01) -
The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
by: A. A. Sheptulin
Published: (2018-08-01) -
High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota
by: Jia-Lun Guan, et al.
Published: (2025-01-01)